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Heart failure (HF) is associated with elevated sympathetic tone and mechanical load.
Both systems activate signaling transduction pathways that increase cardiac output,
but eventually become part of the disease process itself leading to further worsening
of cardiac function. These alterations can adversely contribute to electrical instability, at
least in part due to the modulation of Ca2+ handling at the level of the single cardiac
myocyte. The major aim of this review is to provide a definitive overview of the links and
cross talk between β-adrenergic stimulation, mechanical load, and arrhythmogenesis
in the setting of HF. We will initially review the role of Ca2+ in the induction of both
early and delayed afterdepolarizations, the role that β-adrenergic stimulation plays in the
initiation of these and how the propensity for these may be altered in HF. We will then
go onto reviewing the current data with regards to the link between mechanical load
and afterdepolarizations, the associated mechano-sensitivity of the ryanodine receptor
and other stretch activated channels that may be associated with HF-associated
arrhythmias. Furthermore, we will discuss how alterations in local Ca2+ microdomains
during the remodeling process associated the HF may contribute to the increased
disposition for β-adrenergic or stretch induced arrhythmogenic triggers. Finally, the
potential mechanisms linking β-adrenergic stimulation and mechanical stretch will be
clarified, with the aim of finding common modalities of arrhythmogenesis that could be
targeted by novel therapeutic agents in the setting of HF.
Keywords: heart failure, myocytes, calcium, sympathetic stimulation, stretch, ryanodine, microdomains
Abbreviations: β-AR, β-adrenergic receptor; AC, adenyl cyclase; AP, action potential; BVR, beat-to-beat variability of
repolarization; CaMKII, Ca2+/calmodulin dependent protein kinase II; cAMP, cyclic adenosine 3′,5′-monophosphate;
Casq2, cardiac calsequestrin; CICR, calcium induced calcium release; DAD, delayed afterdepolarization; EAD, early
afterdepolarization; ECC, excitation contraction coupling; Epac, exchange protein activated by cAMP; HF, heart failure;
ITI, transient inward current; LTCC, L-type calcium channel; LVAD, left ventricular assist device; NCX, sodium/calcium
exchanger; NO, nitric oxide; NOS, nitric oxide synthase; NOX2, NADPH oxidase 2; PI3K, phosphoinositide 3-kinase; PKA,
protein kinase A; PLB, phospholamban; ROS, reactive oxygen species; RyR, ryanodine receptor; SACNS, stretch activated
non-selective cation current; SERCA, SR Ca2+-ATPase; SR, sarcoplasmic reticulum; INaL, late sodium current.
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INTRODUCTION
Heart failure is a complex clinical syndrome with many
contributory factors including ischemia, congenital heart disease,
and pulmonary hypertension. HF can be defined as HF with
preserved ejection fraction (HFpEF), when diastolic dysfunction
plays a major role, or HF with reduced ejection fraction
(HFrEF). HF with reduced ejection fraction has been associated
with elevated sympathetic tone and mechanical load (Lohse
et al., 2003). Both systems activate signaling transduction
pathways that increase cardiac output, but adversely contribute
to electrical instability, at least partially via modulation of Ca2+
handling.
The first documentation of alterations in the sympathetic
signaling in chronic HF was when a decrease in concentrations
of the sympathetic nervous neurotransmitter, norepinephrine,
was shown in the failing human heart (Chidsey et al., 1963).
Since that time, there has been accumulating evidence that the
sympathetic nervous system plays a considerable role in HF (Port
and Bristow, 2001) and this is highlighted by the continued
use of β-receptor blockers as a favorable pharmacological
treatment of HF (Waagstein et al., 1993; Ponikowski et al.,
2016).
The hyperadrenergic state is in large part caused by an
imbalance of autonomic reflex responses to early alterations
in cardiac and peripheral hemodynamics (Toschi-Dias et al.,
2017). In HF, vagal control by the baroreceptor reflex is
reduced (Eckberg et al., 1971), while sympatho-excitatory
reflexes are augmented, including the cardiac sympathetic
afferent reflex (Wang and Zucker, 1996). The cardiac-
specific reflex originates in the ventricle and is activated
by elevated filling pressures (Malliani et al., 1973; Wang
and Zucker, 1996), creating a positive feedback loop as its
activation causes excessive sympathetic outflow to the heart
and arteries (Chen et al., 2015). In turn, the heart readapts
its systolic and diastolic force to the adrenergic-mediated
increases in hemodynamic load via intrinsic autoregulatory
mechanisms (Neves et al., 2015). Thus, adrenergic and
hemodynamic regulatory systems tightly interact via a
complex interplay of feedback mechanisms at the local and
systemic level that are initially compensatory, but ultimately
pathological.
Arrhythmias are a major cause of mortality in HF patients,
and sudden cardiac death has previously been linked with a
higher NYHA class (Saxon et al., 2006; Santangeli et al., 2017).
Furthermore, in a recent study, ventricular arrhythmias were
seen in up to 45% of patients who had received a LVAD (Garan
et al., 2013). Although over the last decades remarkable advances
have been made in terms of our understanding of risk factors
and the efficacy of device therapy the underlying mechanisms
responsible for arrhythmia induction and sudden cardiac death
in this population remain elusive, and this is largely down to the
complexity of the disease.
In this review, we will focus on the roles that altered
sympathetic stimulation as well as mechanics may have on
arrhythmogenic phenotype in patients with HF with reduced
ejection fraction, concentrating on alterations of Ca2+ dynamics,
β-adrenergic stimulation and stretch at the level of the single
cardiac myocyte. It is hoped that information gained in this field
will ultimately lead to novel strategies that could improve our
therapeutic arsenal against HF.
BASIC PRINCIPLES OF CALCIUM-
DEPENDENT ARRHYTHMOGENESIS-
AFTERDEPOLARIZATIONS
Before discussing arrhythmogenic mechanisms in HF we need to
understand the basic mechanisms of arrhythmogenesis and the
link to Ca2+.
Afterdepolarizations are thought to be one of the major
mechanisms driving arrhythmogenesis in multiple patho-
physiologies and we will concentrate on these in this review
(Figure 1). These oscillations in the membrane potential can
lead to either triggered activity and/or functional block which
may encourage re-entry circuits (Wit and Rosen, 1983). These
phenomena can be detected at multiple levels, ranging from the
single cardiac myocyte to the tissue and can even be observed
in the intact heart when monophasic APs are recorded (Priori
et al., 1990). They are defined as depolarizations of the cardiac
AP that can occur in phases 2, 3, or 4 of the AP (Cranefield,
1977). When they occur in phase 4 of the AP they are called DADs
whereas if they occur earlier on the AP then they are termed
EADs.
There is now a general consensus that DADs are a result
of a ITI activated by intracellular Ca2+ (Marban et al., 1986).
This ITI was originally described by Lederer and Tsien (1976)
as a result of digitalis-induced arrhythmias and was later
shown to be mainly due to activation of the electrogenic
Na+-Ca2+ exchanger (NCX), while the Ca2+-activated Cl−
current (IClCa) appears to contribute in some species (Fedida
et al., 1987; Zygmunt et al., 1998). Interestingly a study
from Verkerk et al. (2001) showed that ITI in failing human
cardiac myocytes was as a result of NCX alone. In addition
to the potential of DADs to induce arrhythmias via triggered
activity or functional block, recent work has also highlighted
the potential of DADs to increase beat-to-beat variability
of repolarization (BVR) which may also contribute to the
arrhythmogenic nature of these afterdepolarizations (Johnson
et al., 2013). The Ca2+ that activates these arrhythmogenic
currents originate from the SR and is released via diastolic
release events (Venetucci et al., 2008). For these reasons, when
the SR is overloaded with Ca2+, for example during intense
β-adrenergic stimulation, the chance of spontaneous Ca2+
release is increased as is the likelihood for DADs (Yamada and
Corr, 1992).
Mechanisms underlying EADs are much less clear cut
however, and remain a topic of much debate. Early evidence
suggested EADs were caused as a result of reactivation of
ICaL due to the prolonged plateau phase of the AP (January
and Riddle, 1989; Zeng and Rudy, 1995). However, there is
other experimental evidence that suggests that EADs may also
be caused as a result of ITI activation by intracellular Ca2+,
especially under conditions of Ca2+ overload (Priori et al.,
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FIGURE 1 | Stylized examples of afterdepolarizations occurring in the single canine myocyte. Figure shows both membrane potentials and contraction for each
situation. (Left) DAD (∗) induced by the β-adrenergic agonist isoproterenol (ISO); (Middle) illustrates an EAD (#) induced by augmentation of the late sodium current,
using ATX-II; (Right) illustrates that under certain conditions both types of afterdepolarizations can be seen in the same action potential. In this particular example,
blockade of the potassium current, IKs, together with β-adrenergic stimulation are the proarrhythmic treatment and it can be seen that an early aftercontraction
initiates prior to the upstroke of the EAD.
1990; Volders et al., 1997, 2000). Either way, it appears that
EADs are modulated by systolic release of Ca2+ during the
AP and are regulated by feedback on Ca2+ sensitive ion
currents.
The link of afterdepolarizations at the single myocyte level
to arrhythmogenesis at the whole heart level is extremely
complex and incompletely understood. In the intact heart,
myocytes are electrically coupled to each other, meaning
that the membrane voltage is governed by not just one
cell but multiple cells. Furthermore, the contribution of one
afterdepolarization occurring in one cell (the source) will
likely be negated by the neighboring cells not experiencing
afterdepolarizations (the sink). Elegant work from the laboratory
of James Weiss has investigated this phenomenon and has
shown that chaotic EADs are able to synchronize globally
when the tissue is smaller than a critical size. However, when
the tissue is large enough, complete synchronization of EADs
can no longer occur and this results in regions of partial
synchronization that shift in time and space, that can act
as foci for arrhythmia (Sato et al., 2009). Furthermore, work
from the same group also estimated that the number of
local myocyte DADs needed to be synchronized to induce
a premature beat would be very large, however, this could
be reduced structural and electrical remodeling (Xie et al.,
2010). Finally, a recent study from the Bers’ lab has also
highlighted that in HF there is a much higher density of
‘Ca2+ asynchronous’ myocytes that are poorly coupled to the
surrounding myocardium. These poorly coupled myocytes may
also contribute to initiating triggered activity (Lang et al.,
2017).
Over recent years it has become apparent that Ca2+ control
of repolarization, and therefore also of arrhythmogenesis is more
of a local rather than a global phenomenon. Both functional
and structural microdomains dictate local Ca2+ concentrations,
gradients and effector proteins. As these domains appear to
be affected in HF, especially when we consider β-adrenergic
stimulation and stretch we must also consider how this local
control occurs.
LOCAL CONTROL OF Ca2+ RELEASE AT
THE DYAD
In cardiac myocytes, Ca2+ is centrally involved in many
processes including excitability, contraction, and regulation of
gene expression. Such diversity of functional roles postulates
the existence of dedicated microdomains in which Ca2+ signals
are generated independently of cytosolic Ca2+ concentrations
and sensed by macromolecular signaling components localized
to these microdomains. Besides a functional component, Ca2+
microdomains are often physically delimited by specialized
membrane structures and subcellular compartments. Specialized
structures include dyadic junctions between transverse
membrane invaginations (T-tubules) and SR, sarcolemmal
domains outside dyads such as lipid rafts and caveolae, and
intracellular structures such as tethered junctions between
SR and mitochondria. Interestingly, compartmentalization
of proteins that generate or regulate microdomain Ca2+
signaling is dynamic, often as a cause or consequence of
disease. For example, the LTCC, or nNOS coupled to RyR,
can translocate from the dyad to the sarcolemma which alters
their function, presumably by coupling to different signaling
complexes (Sanchez-Alonso et al., 2016; Carnicer et al.,
2017).
Structural Organization
In the dyad, RyR in the SR juxtapose LTCC along T-tubules
at close distances (∼12 nm) (Forbes and Sperelakis, 1983).
Individual dyads control the process of Ca2+ induced Ca2+
release, or CICR. The elementary event is a Ca2+ spark released
from the SR by the opening of RyR in a single Ca2+ release
unit (Cheng and Lederer, 2008). When an LTCC opens during
an AP, the local Ca2+ concentration in the dyad raises much
more than cytosolic Ca2+, from a diastolic level of 100 nM
to more than 10 µM, sufficiently to activate RyR (Cannell
and Kong, 2012). Not all RyR are localized at dyads; non-
coupled RyR are activated through propagated Ca2+ release
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with a delay. Therefore, a large heterogeneity of the tubular
system (e.g., due to T-tubule loss in HF) causes dyssynchrony
of subcellular Ca2+ release during systole (Heinzel et al., 2011).
During diastole, few spontaneous Ca2+ sparks occur due to
the relatively low sensitivity of RyR to resting Ca2+ levels.
A spontaneous release event is spatially confined, but when the
Ca2+ sensitivity or the RyR increases through phosphorylation
or oxidation, or when SR Ca2+ load is high, more spontaneous
Ca2+ sparks summate in time and space into propagating Ca2+
waves.
The structural design of the dyad also provides an optimal
setting for feedback mechanisms of SR Ca2+ release on Ca2+-
regulated membrane currents. Negative feedback through Ca2+
release-dependent inactivation of LTCC serves as a mechanism
to limit Ca2+ influx during the initial phase of the AP (Sham,
1997). As release-dependent inactivation is immediate, following
the fast rise and decline of local Ca2+ near dyads, some of the
LTCC may recover from inactivation within a single beat during
the AP plateau (Acsai et al., 2011). The local feedback of Ca2+
on LTCC may contribute to the intrinsic BVR of the AP in
normal physiology (Antoons et al., 2015). Interestingly, the same
study did not find a major role for the NCX in BVR, although
immunohistochemistry and functional studies have suggested
colocalization of a fraction of NCX with LTCC (10–15% of total
NCX) sensing local Ca2+ release in the dyadic subspace (Acsai
et al., 2011; Scriven and Moore, 2013). In support of this notion,
modulation of (dyadic) Ca2+ sparks by both reverse mode and
forward mode NCX has been demonstrated (Neco et al., 2010;
Biesmans et al., 2011).
To regulate CICR, the dyad harbors a repertoire of kinases and
phosphatases that form macromolecular complexes with LTCC
and RyR and regulate their levels of phosphorylation. PKA and
CaMKII are key to the regulation of LTCC and RyR in the
β-adrenergic and stretch response. PKA is targeted to LTCC and
RyR via AKAPs, and transmits signals from β-ARs via cAMP
(Catterall, 2015; Landstrom et al., 2017). Dyadic cAMP signals
in the vicinity of LTCC and RyR are controlled by localized PDE
activity (Kokkonen and Kass, 2017). It should be noted that exact
mechanisms behind PKA regulation of RyR and its specific role
in the β-adrenergic response are incompletely understood. Marx
et al. (2000) proposed that PKA phosphorylation dissociates
FKBP12.6 from RyR thereby enhancing RyR open probability.
However, this mechanism remains questionable (Xiao et al.,
2004). CaMKII is dually activated by Ca2+ and ROS (Maier and
Bers, 2007), and possibly also by NO at high Ca2+ levels during
β-adrenergic stimulation (Curran et al., 2014). Although CaMKII
is targeted to both coupled and non-coupled RyR via unknown
mechanisms, its activation is confined to the dyad, where it
enhances the open probability of RyR and LTCC (Wehrens et al.,
2004; Bers and Morotti, 2014).
Reactive Oxygen Species
In addition to phosphorylation mechanisms, ROS and NO have
emerged as critical regulators of CICR. They modify LTCC
and RyR function through redox modification of free cysteine
residues. The action of ROS and NO is often multiphasic and
bidirectional, depending on source, oxidant species, amount and
timing and importantly, the local redox environment (Zima
and Blatter, 2006). Typically, free radicals are short-lived and
can only act on effectors in the close vicinity. Thus, redox
modulation of Ca2+ in a cardiac myocyte is basically a tale
of microdomain signaling of which the specific effects are
determined by the subcellular location of the ROS/NO source
and co-localization with its target proteins. Endogenous ROS are
generated in the mitochondria as a by-product of respiration, and
locally in the cytosol by specialized enzymes, such as NADPH
oxidases (Burgoyne et al., 2012). Much of the O2− produced
is rapidly converted to H2O2, a more stable and membrane
permeable derivative. Endogenous NO is produced in relatively
low concentrations by endothelial and neuronal isoforms of NOS
(eNOS and nNOS, respectively) (Massion et al., 2003).
An important player in the redox control of dyadic Ca2+
is NOX2, a membrane-bound NADPH oxidase that resides in
T-tubules. NOX2 is induced by fast pacing and stretch, and
activates RyR via S-glutathionylation (Sánchez et al., 2005). RyR
activation by rapid pacing also requires CaMKII, which itself is
redox regulated (Erickson et al., 2008). Interestingly, the NOX2-
CaMKII regulation of RyR is restricted to the dyadic cleft. In pig
myocytes that resemble human and have a significant population
of non-coupled RyR, faster pacing significantly increased Ca2+
spark activity of dyadic RyR, but not the activity of non-coupled
RyR. Additionally, NOX2 and CaMKII inhibition abolished Ca2+
sparks in dyadic regions, but not near non-coupled regions (Dries
et al., 2013). At this point it cannot be concluded if NOX2-
derived ROS is upstream of CaMKII oxidation [as suggested
in models of oxidative stress induced by angiotensin (Erickson
et al., 2008; Purohit et al., 2013)] or whether NOX2 and CaMKII
act in parallel. Furthermore, exact mechanisms of microdomain-
specific activation of NOX2 and CaMKII in response to rapid
pacing remain elusive. NOX2 is also activated by stretch. Prosser
et al. (2011) have demonstrated that stretching a myocyte
triggered an immediate burst of ROS and Ca2+ sparks. The ROS
was derived from NOX2 as the response was sensitive to NOX2
inhibitors and absent in NOX2 deficient mice (Prosser et al.,
2011).
In contrast to NOX2, mitochondria constitutively produce
ROS. Mitochondria are located at a very short distance of dyadic
regions [between 37 and 270 nm based on electron microscopy
analysis of rat myocardium (Sharma et al., 2000)]. Several studies
have shown that mitochondrial ROS can activate RyR (reviewed
in Zhang H. et al., 2013), suggesting that basal ROS production
by mitochondria is responsible for a significant portion of
spontaneous Ca2+ sparks (Yan et al., 2008).
The LTCC also acts as a redox sensor due to free thiol
groups in its α1-subunit (Muralidharan et al., 2016). Reported
ROS effects on Ca2+ channel function are both stimulatory
(Song et al., 2010), or inhibitory (Gill et al., 1995). This
discrepancy might be due to differences in the phosphorylation
state of the Ca2+ channel. Several serine/threonine kinases
that regulate the channel are subjected to ROS modification,
including PKA, PKC, and CaMKII (see Burgoyne et al., 2012, for
review). The positive effects of phosphorylation might partially
counterbalance the inhibitory effects of direct ROS oxidation of
LTCC. During high oxidative stress, LTCC facilitation by CaMKII
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is likely the predominant effect, since the calcium antagonist
nifedipine could suppress the induction of EADs by H2O2 (Xie
et al., 2009). ROS regulates many other proteins of the Ca2+
machinery outside the dyad. The overall effect of sustained
ROS is Na+ and Ca2+ overload promoting even more ROS
production via positive feedback and predisposing the cell to
afterdepolarizations (Wagner et al., 2013).
Nitric oxide is both a positive and a negative regulator
of excitation–contraction (EC) coupling underscoring the
complexity of cardiac NO signaling (Simon et al., 2014; Farah
et al., 2018). NO exerts its action via two pathways: an indirect
pathway by the activation of sGC producing cGMP, and a direct
pathway by S-nitrosylation of proteins. High levels of NO would
predominantly stimulate the cGMP pathway causing negative
inotropy, while low levels activate nitrosylation processes leading
to positive inotropy (González et al., 2008). The mechanisms
of nitrosylation, and particularly its effects on EC coupling,
remain poorly understood. Despite much controversy, some
consensus has emerged on the specific roles of eNOS and nNOS
highlighting the importance of their subcellular localization in
modulating Ca2+ handling proteins. Colocalization of eNOS
and LTCC in caveolae at the sarcolemma favors S-nitrosylation
and inhibition of LTCC (Wang et al., 2008). nNOS is targeted
to the SR where it colocalizes with RyR and is therefore
considered the prime NO modulator of dyadic Ca2+ (Barouch
et al., 2002). NO nitrosylates RyR and increases its activity
(Wang et al., 2010, but see also Zahradníková et al., 1997).
The notion that the positive effects of nNOS are linked to
its specific localization on the SR has been supported by a
recent study that developed a transgenic mouse model in
which nNOS was targeted to the sarcolemma and no longer
co-localized with RyR (Carnicer et al., 2017). Interestingly,
relocalization of nNOS, as may occur in HF, produced the
same negative effects on ICaL and contraction as eNOS. In
normal physiology, NOS activity is controlled by β-adrenergic
stimulation and stretch, as will be discussed in the next
paragraphs.
β-ADRENERGIC SIGNALING AND
AFTERDEPOLARIZATIONS
In the heart, enhanced sympathetic activity is a potent
stimulus for generation of arrhythmias. The relationship between
sympathetic stimulation and triggered activity has long been
recognized, in vivo (Priori et al., 1988, 1990) and in vitro
(Lazzara and Marchi, 1989). During β-adrenergic stimulation,
DADs and EADs often coexist. When Ca2+ overload plays
a role in afterdepolarization formation, as could be the case
under β-adrenergic stimulation, both EADs and DADs can
be abolished by ryanodine, suggesting a common dependence
of these on SR Ca2+ release under these conditions. In
cardiac myocytes, β-ARs and their effector pathways targeting
Ca2+ handling proteins are highly compartmentalized. In
this paragraph, we will discuss the parallel activation of
multiple molecular pathways by β-adrenergic subtypes, their
specific end targets to controlling local and global Ca2+
release, and their impact on the generation of DADs and
EADs.
β-Adrenergic Signaling Pathway
β-Adrenergic stimulation activates two pathways that operate
in parallel: a PKA-dependent pathway that impacts on systolic
Ca2+ through modulation of SR Ca2+ load, and a CaMKII
pathway that regulates diastolic SR Ca2+ release (Figure 2A).
Molecularly, the PKA signaling cascade is clearly defined. Upon
activation, β-adrenergic agonists stimulate adenylate cyclase via
Gs-coupled proteins raising cAMP levels that activates PKA
(Bers, 2002). Subsequent phosphorylation of PKA substrates,
including LTCC (causing increased Ca2+ influx) and PLB
(accelerating SR Ca2+ uptake), results in enhancement of SR
Ca2+ load. In cardiac myocytes, the compartmentation of cAMP
signaling has been attributed to different β-AR subtypes that
have distinct subcellular locations. β2 receptors are preferentially
located at T-tubules where they co-localize with LTCC in
caveolae, while β1 receptors are distributed more globally
across T-tubules and surface sarcolemma. Using FRET sensors
for cAMP, it was demonstrated that selective β1 stimulation
generates cAMP signals that propagate throughout the cell,
whereas the β2 AR signal is locally confined in T-tubules
and specifically regulates LTCC during CICR (Nikolaev et al.,
2006).
In vitro, PKA can also phosphorylate RyR (Marx et al.,
2000), but in intact myocytes a functional role for PKA
regulation of RyR remains controversial. Most evidence is
in favor of CaMKII as the prime modulator of RyR during
β-adrenergic stimulation. In response to adrenergic activation,
CaMKII phosphorylates RyR and increases open probability
when measured as SR Ca2+ leak (Curran et al., 2007) or
diastolic Ca2+ sparks (Gutierrez et al., 2013). A recent study
in pig myocytes suggested that CaMKII-dependent modulation
of RyR during β-adrenergic stimulation was restricted to RyRs
specifically in the dyadic cleft, and involved local activation of
nNOS (Dries et al., 2016). The nNOS/CaMKII effects were not
observed in RyR release sites that were not coupled to T-tubules.
While there is conclusive evidence to support nNOS involvement
in β-adrenergic modulation of RyR (Massion et al., 2003), the
steps upstream from nNOS activation are less well defined. Some,
but not all, studies suggested the involvement of Epac, a cAMP
target parallel to PKA, leading to CaMKII autophosphorylation
and downstream RyR phosphorylation (Pereira et al., 2007;
Oestreich et al., 2009). A second pathway, independent of
cAMP, involves PI3K and Akt as upstream activators of nNOS
inducing CaMKII activation via nitrosylation (Curran et al.,
2014). A recent study suggested that the Epac and nNOS pathway
are interdependent and function largely in series (Pereira et al.,
2017).
During β-adrenergic stimulation, the cAMP-PKA and nNOS-
CaMKII pathways operate in parallel. From the current evidence
it is clear that PKA signaling is distributed more globally
with robust effects on LTCC and SERCA, whereas CaMKII is
highly localized and exerts stronger effects than PKA on RyR.
Ca2+ current facilitation by CaMKII under β-AR has also been
demonstrated (Dries et al., 2016). The integrated response is
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FIGURE 2 | Proposed pathways for inducing SR Ca2+ leak during β-adrenergic signaling and stretch in a ventricular cardiomyocyte. (A) β-AR raises cAMP levels via
Gs-protein-dependent activation of AC that activates both PKA and Epac. PKA phosphorylates LTCC and PLB leading to more Ca2+ influx and faster uptake by
SERCA into the SR. Epac activates nNOS and CaMKII via an PI3K and AkT signaling cascade promoting SR Ca2+ leak via RyR phosphorylation. The broken line
indicates a cAMP and Epac-independent pathway for local activation of nNOS targeted to RyR in the dyad. RyR not coupled to LTCC in T-tubules are not modulated
by CaMKII and nNOS. eNOS is localized to caveolae and exerts negative effects on LTCC during β-adrenergic stimulation. (B) Mechanotransduction involves ROS
and NO for RyR activation. The ROS and NO pathway are independent and operate on different timescales via different mechanosensors. NOX2 produces ROS near
RyR in the dyad increasing RyR activity possibly via oxidation of CaMKII. With a delay, nNOS is activated via an unknown mechanosensing mechanism. The
enhanced SR Ca2+ leak promotes Ca2+ waves that activate a transient inward NCX current causing DAD. Caveolar eNOS is activated by stretch via PI3K-Akt and
positively modulates EC coupling outside the dyad by mechanisms that are incompletely understood. See text for further details. AC, adenyl cyclase; β-AR,
β-adrenergic receptor; cAMP, cyclic adenosine 3’,5’-monophosphate; CaMKII, Ca2+/calmodulin-dependent protein kinase II; EC, excitation contraction; DAD,
delayed afterdepolarizations; eNOS, endothelial nitric oxide synthase; Epac, exchange protein activated by cAMP; LTCC, L-type Ca channel; NCX, Na+/Ca2+
exchanger; NO, nitric oxide; NOX2, NADPH oxidase type 2; nNOS, neuronal nitric oxide synthase; PI3K, phosphoinositide 3-kinase; PKA, protein kinase A; PLB,
phospholamban; ROS, reactive oxygen species; RyR, ryanodine receptor; SERCA, SR Ca2+-ATPase; SR, sarcoplasmic reticulum.
enhancement of LTCC currents, SR Ca2+ load and leak. Together,
these effects are able to favor both EADs and DADs.
Ca2+-Dependent Mechanisms of
Afterdepolarizations During β-Adrenergic
Stimulation
The link between β-adrenergic stimulation, RyR-mediated Ca2+
leak and arrhythmogenesis has been most convincingly
demonstrated in the clinical case of catecholaminergic
polymorphic ventricular tachycardia (CPVT). Patients with
CPVT carry mutations in RyR that increase the open probability
of the receptor, or in calsequestrin (Casq2) where SR Ca2+
buffering is hindered and/or the interaction of Casq2 and RyR
is altered (Cerrone et al., 2009). Introducing a CPVT associated
RyR mutation in a mouse model, for example, resulted in a
higher rate of Ca2+ sparks, waves and DADs in myocytes,
and development of bidirectional ventricular tachycardia after
exposure to catecholamines (Cerrone et al., 2005; Liu et al.,
2006; Fernández-Velasco et al., 2009). The higher incidence of
DADs and triggered activity has been attributed to increased
RyR sensitization to Ca2+ (lowering the SR threshold for
Ca2+ waves), and the enhanced SR Ca2+ by catecholamines
(Fernández-Velasco et al., 2009; Kashimura et al., 2010). DAD
occurrence also critically depends on the balance between SR
Ca2+ load and the diastolic interval. Short durations reduce the
time for SR refilling and recovery, and hence the likelihood of
DADs. CPVT patients sometimes develop bradycardia. In this
population the slow supraventricular rate has been suggested
as the primary cause of ventricular arrhythmias (Faggioni
et al., 2013), which may explain the reduced response of some
patients to β-blockers (Priori et al., 2002). During bradycardia,
particularly the Purkinje cells of the conduction system are prone
to developing DADs and present a major source of focal activity
in CPVT (Cerrone et al., 2007).
In conditions of excessive Ca2+ load, DADs and EADs often
appear simultaneously (Priori and Corr, 1990; Volders et al.,
1997; Antoons et al., 2007). A study by Johnson et al. (2013) in
dog ventricular myocytes proposed a mechanism that coupled
diastolic DADs to increased BVR and EADs. In the presence
of isoproterenol, diastolic Ca2+ waves and DADs frequently
appeared between beats. After a DAD, the duration of the next
AP was consistently prolonged, related to an increase in ICaL. The
Ca transient during CICR was smaller after a DAD (presumably
due to partial SR depletion), and modeling and voltage-clamp
analysis explained the ICaL facilitation by a reduction of Ca2+
dependent inactivation of ICaL. The feedback of DAD on ICaL
caused significant BVR. Furthermore, because of the prolonged
AP after a DAD, new Ca2+ waves could be generated before the
end of repolarization and form EADs.
The phenomenal observation of Ca2+ sparks and waves that
occur due to spontaneous (not triggered) openings of RyR
clusters during diastole is well known (Cheng and Lederer,
2008). Triggered Ca2+ sparks, i.e., produced by LTCC openings
during CICR, occur near-synchronously at the start of the Ca2+
transient and are not expected to occur during relaxation because
of refractoriness of the RyR and SR Ca2+ content. However,
using high sensitivity detectors during confocal imaging in rabbit
ventricular myocytes, Fowler et al. (2018) detected Ca2+ sparks
during the decay of the Ca2+ transient. They explained the
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occurrence of these late Ca2+ sparks by the ability of release
sites to recover from refractoriness during the plateau phase of
the AP to become reactivated either by cytosolic Ca2+ itself,
or by stochastic openings of LTCC. Late Ca2+ sparks are more
readily observed when CaMKII activity is increased, as was
reported in a mouse model of CaMKIIδc overexpression (Guo
et al., 2012). CaMKII phosphorylation of LTCC causes a shift
in the distribution of LTCC into high-activity gating modes and
accelerates recovery from inactivation (Sham et al., 1995; Guo
and Duff, 2006), which could explain the facilitation of late Ca2+
sparks by CaMKII. Interestingly, repetitively firing of late Ca2+
sparks produced microscopic waves of Ca2+ release presenting a
new paradigm of electrical instability underlying BVR and EAD
(induced by a DAD-like mechanism during the AP plateau),
particularly in settings of HF with prolonged AP and increased
CaMKII activity.
A final mechanism of EAD seen with β-AR relates to
the dynamic modulation of Ca2+ window currents through
Ca2+-dependent feedback. The mechanism is independent of
spontaneous Ca2+ events (unlike the mechanisms discussed
above) but reflects local feedback of SR Ca2+ release on
LTCC during CICR. In the classical view, EAD are caused by
voltage-dependent recovery of inactivated LTCC. Inactivation
and recovery of LTCC also have a Ca2+-dependent component
(Sipido et al., 1995; Sham, 1997), dynamically shaping Ca2+
window currents during a single beat. In dog and pig myocytes,
we observed that under isoproterenol Ca2+-dependent recovery
of window currents was faster than the decay of global Ca2+
transients, relatively unaffected by slow Ca2+ buffers and absent
when SR Ca2+ release was inhibited (Antoons et al., 2007; Acsai
et al., 2011). These data strongly suggest that release-dependent
recovery of window currents is driven by local changes in dyadic
Ca2+. The Ca2+-dependent regulation of Ca2+ window currents
seem to require sufficiently high levels of dyadic Ca2+, or local
activation of CaMKII, as the dynamic inactivation and recovery
process was no longer observed in the absence of isoproterenol.
Enhanced dynamic modulation of window LTCC by dyadic Ca2+
release is a suggested source of BVR (Antoons et al., 2015), and
may contribute to an increased incidence of EADs under β-AR
stimulation (Antoons et al., 2007).
MECHANICAL LOAD AND
AFTERDEPOLARIZATIONS
Acute stretching of the heart destabilizes membrane potential and
causes DADs and EADs (Franz et al., 1989). This arrhythmogenic
activity is caused by negative feedback mechanisms that integrate
mechanical and electrical activity of cardiac myocytes and
presumably involve Ca2+ (Ravens, 2003). The myocardium
responds to stretch by a more powerful contraction, a
phenomenon referred to by Frank Starling (Sagawa et al., 1990).
The intrinsic adaptation to changes in mechanical load has a
second slower component of enhanced contractility described
by the Anrep effect (von Anrep, 1912). Early work in intact
cardiac muscle had not observed significant changes in diastolic
and systolic global Ca2+ levels during the initial stretch response
(Allen and Kurihara, 1982), which has argued against a major
role for Ca2+ in stretch-induced arrhythmias. More recently,
this view has been challenged by experiments that confocally
monitored Ca2+ sparks and waves during stretch, suggesting
that local Ca2+ release could account for at least part of
the Frank Starling response (Petroff et al., 2001). Since then,
a complex picture of mechanosensitive Ca2+ signaling has
emerged that operates over a wide range of time scales. Within
milliseconds, a small diastolic stretch triggers a burst of Ca2+
sparks (Iribe et al., 2009). When sustained, Ca2+ accumulates
over minutes via stretch-induced autocrine/paracrine signaling
participating in the Anrep effect (Cingolani et al., 2013). When
stress becomes chronic, elevated Ca2+ influx activates gene
expression leading to hypertrophy (Tavi et al., 2001; Gómez et al.,
2013).
RyR Mechanosensitivity
Stretch-dependent regulation of the Ca2+ system is operated
via the process of mechanotransduction. Its mechanisms involve
many signaling cascades targeting a diversity of intracellular
Ca2+ sources, including the SR and mitochondria (Schönleitner
et al., 2017). Furthermore, mechanotransduction operates via
different classes of mechanosensors of which the activation seems
to depend on the mechanical environment of the myocyte, which
in experimental settings is defined by the dimensionality of the
stretch system (Chen-Izu and Izu, 2017). The modulation of RyR
by mechanical force has been a focus of investigation after the first
demonstration in a 3D cell-in-gel system that stretch can trigger
Ca2+ sparks (Petroff et al., 2001). Subsequently, ROS and NO
have been identified as key molecules in RyR mechanosensitivity
(Figure 2B). NOX2 activation has been proposed as the principle
mechanosensor underlying the initial fast response of Ca2+
sparks to stretch (Prosser et al., 2011). Stretch-induced ROS by
NOX2 is fast, transient and confined near the dyad to permit
rapid and reversible modification of RyR. It is therefore believed
that the NOX2 pathway enhances CICR efficiency without
changes in systolic Ca2+ and serves as an adaptation to beat-
to-beat variations in preload contributing to the Frank Starling
response.
Cardiac stretch also stimulates cardiomyocytes to produce
NO (Khairallah et al., 2012). Mechanical stimulation of NO
elevates the systolic Ca2+ transient and produces spontaneous
Ca2+ sparks during diastole, as was demonstrated in myocytes
contracting in-gel against a higher preload or afterload (Petroff
et al., 2001; Jian et al., 2014). In these settings, NO was produced
through activation of constitutive NOS by phosphorylation via
the PI3K-Akt pathway (Petroff et al., 2001). Pharmacological
inhibition or genetic deletion to differentiate between eNOS
and nNOS pathways revealed that both isoforms were involved
in the downstream effects on systolic Ca2+, but only nNOS
had a role in the induction of Ca2+ sparks (Jian et al., 2014).
The divergent effects of eNOS and nNOS have been explained
by their subcellular location. nNOS is localized at the dyad in
close proximity of RyR, while eNOS is spatially confined in
caveolae more distant from RyR release sites (Xu et al., 1999).
Downstream from nNOS signaling, CaMKII was also found
to modulate afterload-induced Ca2+ sparks. The mechanically
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induced SR Ca2+ leak by nNOS is expected to deplete the SR of
Ca2+, however, SR Ca2+ content is maintained presumably via
enhanced SERCA Ca2+ reuptake by nNOS (Vielma et al., 2016).
The NO-mediated increase of the Ca2+ transient to
compensate for greater mechanical load typically appears with
a delay of seconds and minutes, possibly participating in the
Anrep effect. Trans-sarcolemmal Ca2+ influx also contributes
to the slow Ca2+ loading during stretch. One of the proposed
mechanisms is increased activity of Na+/H+ exchanger through
mitochondrial ROS release downstream of stretch-induced
angiotensin signaling (Cingolani et al., 2013). The result is an
increase in intracellular Na+ that stimulates reverse NCX loading
the cell with Ca2+. Na+ and Ca2+ influx through non-selective
cationic SAC may further contribute (Calaghan et al., 2004).
Thus, slow adaptation to stretch is viewed as an enduring signal
achieved by concerted action of local nNOS activity to fine-tune
local Ca2+ release and transsarcolemmal Ca2+ and Na+ influx to
gain more Ca2+.
Ca2+-Dependent Mechanisms of
Stretch-Induced Arrhythmias
While mechano-sensitization of RyR is part of an effective
adaptation to preload and afterload by increasing the efficiency
of local Ca2+ release, it also produces spontaneous Ca2+ sparks
during diastole. In the normal heart, stretch-induced Ca2+
sparks are locally confined. Under certain conditions, when
more Ca2+ sparks arise synchronously to form Ca2+ waves, the
load-adaptive Ca2+ system could turn into an arrhythmogenic
mechanism. The stretch-induced increase in ROS, Ca2+ sparks
and velocity of propagating Ca2+ waves is graded, i.e., increases
with increasing amount of stretch (Miura et al., 2015). Thus,
large stretches, such as in dilated hearts, are more likely to
trigger ventricular ectopy (Hansen et al., 1990). Mechanical
dyssynchrony, often due to structural tissue heterogeneity, is
a further compromising factor. In case of dyssynchronous
contractions, Ca2+ waves arise from a non-SR source as result
from Ca2+-dissociation from the contractile filaments during
late relaxation of the non-uniform cardiac muscle (Miura et al.,
2008).
More ROS can also by produced by hypersensitivity of
mechanosensitive signaling due to upregulation of a molecular
component, as was demonstrated for a mouse model of
Duchenne muscular dystrophy that showed upregulation of
NOX2 and produced Ca2+ waves in response to moderate stretch
(Prosser et al., 2011). In addition to DADs, ROS also activates
EADs, via reactivation of ICaL (Song et al., 2010), or enhanced
late Na+ current (Song Y. et al., 2006). While RyR, INaL, and
LTCC can be directly activated by oxidation (Xu et al., 1998;
Morita et al., 2003; Kassmann et al., 2008), redox modification
of CaMKII seems to be crucially involved in ROS modulation
of arrhythmogenic INaL and LTCC currents (Morita et al.,
2009; Wagner et al., 2011). Of note, most electrophysiology
studies applied H2O2 as an exogenous source of ROS. There
are no current data to confirm if endogenous ROS produced
by NOX2 during stretch behaves similarly. Source matters, as
mitochondrial ROS caused a reduction of INa (Liu et al., 2010).
While ROS is a ubiquitous proarrhythmic signal, NO generate
opposite pro- and antiarrhythmic signals that can be partly
explained by divergent effects of eNOS and nNOS on Ca2+
handling proteins. Mice with targeted disruption of eNOS
had a higher incidence of arrhythmias induced by ouabain
(Rakhit et al., 2001) or β-adrenergic stimulation (Wang et al.,
2008), confirming earlier work reporting on the protective
effects of NO against ventricular arrhythmias in dogs (Vegh
et al., 1992). The antiarrhythmic effects have been attributed
to β-adrenergic antagonism of eNOS via reduction of ICaL in
a cGMP-dependent manner. Likewise, nNOS knockout mice
suffered more from arrhythmias after myocardial infarction
than their WT littermates. Because an ICaL blocker reduced VF
incidence, the authors concluded that nNOS is antiarrhythmic
through ICaL inhibition via direct nitrosylation (Burger et al.,
2009). Nitrosylation of the Na+ channel is also coupled to
nNOS activity (Ahern et al., 2000). Conversely, when nNOS
is activated by stretch or catecholamines in cardiac myocytes,
local NO-CaMKII signals produce arrhythmogenic Ca2+ waves
that originate from dyadic RyR (Curran et al., 2014; Jian et al.,
2014). Giving the pro-arrhythmic actions of isoproterenol in vivo,
it is reasonable to argue that during β-adrenergic stimulation
in the presence of mechanical load, pro-arrhythmogenic nNOS
signaling prevails.
In unloaded myocytes, the ITI following a Ca2+ wave is
mainly produced by NCX. In stretched myocytes, a significant
contribution of stretch-activated channels is anticipated. Stretch-
activated non-selective cation currents (SACNS) have been
functionally demonstrated in ventricular myocytes at the whole-
cell and single-level (Craelius et al., 1988). While it is unlikely
that Na+ and Ca2+ conducting SACNS participate in stretch-
induced SR Ca2+ release in ventricular myocytes (Iribe et al.,
2009), they may contribute to destabilize the resting membrane
potential by generating inward current during diastole. Studies in
whole hearts demonstrating anti-arrhythmic effects of GsMTx-
4, a specific SACNS blocker, support the involvement of SAC in
stretch-induced arrhythmias (Wang et al., 2016). The search for a
‘true’ SACNS, a structural homolog to the bacterial SAC that can
be directly gated by membrane tension (Sukharev et al., 1994), is
still ongoing. Interestingly in this regard is the discovery of Piezo
channels in a neuroblastoma cell line (Coste et al., 2010). The
biophysiological profile of Piezo matches endogenous cardiac
SACNS, including weak voltage dependency, single channel
conductance, inactivation, and sensitivity to GsMTx-4 (Gottlieb,
2017), and is therefore a promising candidate. Piezo is expressed
at low levels in the heart (Coste et al., 2010), but its role in cardiac
function has yet to be established.
In the heart, the search for cardiac SACNS has been largely
focused on the transient receptor potential canonical (TRPC)
channel family. The activation of TRP channels is polymodal,
and some members are directly activated by membrane
deformation (Inoue et al., 2009), although this remains somewhat
controversial (Gottlieb et al., 2008). Two subtypes, TRPC3 and
TRPC6, have been proposed as potential candidates participating
in the slow force response (Yamaguchi et al., 2017). Hyperactive
TRPC3 (Doleschal et al., 2015) or TRPC6 (Seo et al., 2014)
amplified the slow inotropic response to stretch resulting in Ca2+
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overload and arrhythmogenesis. Doleschal et al. (2015) explained
the pro-arrhythmia of TRPC3 by a Ca2+ overload dependent
mechanism that involves spatial uncoupling between TRPC3
and NCX1 in specialized microdomains disrupting the tight
regulation of NCX by local Ca2+ and Na+. This thinking is in
line with the conceptual view that TRPC channels have access to
localized Ca2+ signaling microdomains that are separated from
contractile dyadic signaling (Houser and Molkentin, 2008). The
microdomain concept was initially proposed to explain the role
of TRPC channels in the activation of the NFAT/calcineurin axis
linking pathophysiological hypertrophy to chronic mechanical
stretch (Kuwahara et al., 2006; Makarewich et al., 2014).
It has been well established that structural and functional
remodeling in pathological cardiovascular stress predisposes
the heart to arrhythmias (Nattel et al., 2007; Orini et al.,
2017).
Linking Mechanotransduction and
Adrenergic Signaling
Thus far, ROS, NO, and CaMKII have been identified as the
prime mediators of RyR mechanosensitivity in the intrinsic
adaptation of contractile force to load. In vivo, intrinsic force
adaptation is modulated by sympathetic activation by imposing
a higher load on the heart through modulation of vascular tone.
The myocyte can respond to higher mechanical and adrenergic
stress through activation of mechanotransduction and adrenergic
signaling networks, as discussed above and depicted in Figure 2,
but interactions have not been systematically investigated. The
mechanotransduction pathway shows both the rapid preload-
induced NOX2 and slower afterload-induced NO branch, that
most probably operate independently (Jian et al., 2014). It is
also unlikely that NOX2 is directly involved in β-adrenergic
signaling, since ROS scavengers failed to prevent increases
in Ca2+ spark frequency in quiescent cells that were treated
with isoproterenol (Gutierrez et al., 2013). It should be noted
that NOX2 can possibly become activated during β-adrenergic
signaling as an indirect consequence of chronotropic effects
(Dries et al., 2013).
nNOS is centrally involved in both stretch- and adrenergically
induced Ca2+ sparks, most likely via oxidation of downstream
CaMKII (Gutierrez et al., 2013; Jian et al., 2014). It is
therefore tempting to speculate that nNOS and CaMKII act
as primary integrators of mechanotransduction and adrenergic
RyR signaling networks. The assumption that co-activation of
nNOS has a cumulative effect on RyR activity remains to be
determined.
The eNOS effects are less clearly defined. eNOS is
compartmentalized in caveolae at T-tubules and sarcolemma.
In sarcolemmal caveolae, eNOS colocalizes with β-ARs and
LTCC allowing NO to mitigate β-adrenergic inotropy through
inhibition of LTCC by local cGMP (Wang et al., 2008). It
is conceivable that a stretch activation of the eNOS-Akt-
PI3K pathway positively modulates EC coupling gain in
T-tubular caveolae, while negatively regulating the β-adrenergic
response in a different subset of caveolae at the surface
sarcolemma.
HEART FAILURE AND
AFTERDEPOLARIZATIONS
Heart failure is associated with extensive cardiac remodeling,
at both the structural and functional levels. Remodeling due to
HF occurs for a number of reasons, however, it is in part, due
to altered stress on the ventricular wall (Kehat and Molkentin,
2010).
Remodeling can lead to an increased propensity for complex
ventricular arrhythmias and sudden cardiac death, and these
are seen in over half of the patients presenting with HF with
reduced ejection fraction. For these reasons it is imperative
to understand the mechanisms that are responsible for the
increased arrhythmia incidence in this population (Janse,
2004).
Purkinje fibers isolated from infarcted sections of human
hearts have been shown to have significantly longer APD than
those from non-infarcted zones, resulting in marked dispersion
of APD in infarcted and adjacent zones. Furthermore, both
epinephrine and the cardiac glycoside, ouabain, were able to
induce DADs in these fibers (Dangman et al., 1982). Previous
work using human trabeculae has also shown that there is
an increased propensity for triggered activity in tissue from
HF patients (Vermeulen et al., 1994). Further work from
the Amsterdam group also showed that, in contrast to many
animal species, norepinephrine induces APD prolongation in
ventricular myocytes from human failing hearts, as well as
EADs. These alterations were ascribed to an increase in both
the calcium peak current and window current (Veldkamp et al.,
2001).
In addition to the alterations in arrhythmia incidence in HF,
it has been well described that the failing heart has a reduced
responsiveness to elevated catecholamine levels, at least in end-
stage HF, due to alterations in expression of β-ARs (Bristow
et al., 1982; Ungerer et al., 1993). Interestingly, more recent
work has also shown that in a patient cohort with HF, BVR
of ventricular AP duration was increased during an autonomic
challenge associated with increased sympathetic activity (Porter
et al., 2017).
Taking these data together leads us to believe that
modifications in signaling underlying β-adrenergic
responsiveness and stretch may contribute to the increased
occurrence of arrhythmias in these patient populations.
Therefore, if we are able to understand the precise changes
that occur in these systems during HF, we may get a better
hold on the processed occurring, with an outlook of preventing
and/or treating the, potentially, maladaptive remodeling (see
below).
Global Remodeling
At the gross structural level, the geometry of the heart changes as
a result of HF, becoming less elliptical and more spherical (Cohn
et al., 2000). HF is associated with a progressive enlargement of
the left ventricle, with increases in end-systolic left ventricular
wall stress being seen (Florea et al., 1999), which may have
detrimental effects on mechanosensitive mechanisms involved
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in arrhythmia formation, and also contribute to the cellular
arrhythmogenic remodeling.
Ion Channel Remodeling
At the level of the single myocyte, changes in HF include
alterations in the densities of various membrane channels, which
contributes to the increase in APD seen in the majority of HF
models and in patients (Beuckelmann et al., 1993; Tomaselli
and Marbán, 1999). One of the most consistent findings with
regards to current alterations in HF is the decrease in the
inwardly rectifying potassium current, IK1, which contributes
to maintaining the resting membrane potential as well as
contributing to terminal repolarization (Beuckelmann et al.,
1993; Nerbonne and Kass, 2005). Furthermore, the β-adrenergic
regulation of IK1 has also been shown to be significantly reduced
in myocytes isolated from HF patients (Koumi et al., 1995).
Reduced IK1, will mean that a smaller ITI will be required to
cause the same amplitude of DAD, or even triggered AP, and
therefore altered regulation of this current in HF has major
implications in the potential arrhythmogenic outcomes. An
interesting recent study, however, showed that sympathetically
-induced arrhythmias could not be induced when IK1 was
inhibited in isolation in Langendorff-perfused rabbit hearts
indicating that synergistic activity between multiple pathways,
including altered RyR sensitivity, was required for arrhythmia
induction (Myles et al., 2015).
Another potassium current that is of great interest when it
comes to β-adrenergic modulation, is the slow rectifier, IKs. IKs
function is prominent during β-adrenergic stimulation when it
promotes AP shortening, to counteract the increase in inward
Ca2+ current, thus providing critical “reserve” when other
repolarizing currents are impaired (Jost et al., 2005; Varró et al.,
2000; Volders et al., 2003). Although Veldkamp et al. (1995) could
not detect this current in myocytes isolated from patients with
cardiomyopathy, a number of animal models have indicated that
this current is downregulated in HF (Tsuji et al., 2000; Li et al.,
2002). A decrease in this current during intense sympathetic
stimulation will lead to an increase in APD, and an increased
tendency for afterdepolarizations. Furthermore, research from
our own group has shown the key role that IKs plays in
preventing excessive BVR during β-AR stimulation, which may
also contribute to the arrhythmogenic substrate generated when
this current is downregulated (Johnson et al., 2010, 2013).
The importance of both IK1 and IKs and their regulation
by β-adrenergic stimulation in HF were recently highlighted
by a study from the Bers’ group. In this manuscript, the
physiologically relevant AP-clamp technique was utilized to show
that under β-adrenergic stimulation, reduced IKs responsiveness
limits the integrated repolarizing potassium currents in a rabbit
model of HF. Furthermore, an increase in APD BVR was seen in
HF myocytes. Taken together these data illustrate the importance
that these currents may play in arrhythmia generation in
HF, especially under sympathetic stimulation (Hegyi et al.,
2018a).
Apart from the acute effects of adrenergic stimulation
on channel activity, one must also consider the effect of
sustained sympathetic activation. A recent study did just this by
investigating the effects of sustained adrenergic stimulation on
IKs dynamics. In that particular study, they showed that IKs was
reduced after continued β-AR stimulation, and this was mediated
by CaMKII, a signaling molecule involved in both β-AR and
mechanosensitive stimulated arrhythmias (Shugg et al., 2018). If
this effect contributes to the increased incidence of arrhythmias
in HF is currently unknown and should be the subject of further
work.
With regards to the acute effect of HF on SACNS, that may also
contribute to stretch-induced arrhythmias, multiple laboratories
have shown that TRPC channel expression and activity are
upregulated in pathological hypertrophy and HF (Eder and
Molkentin, 2011). Furthermore, to our knowledge, to date only
one study has investigated the level of Piezo channels in HF, with
that study providing evidence of an upregulation in HF. However,
the functional consequences of this upregulation are currently
unknown and should be the subject of further research (Liang
et al., 2017).
Excitation–Contraction Coupling Remodeling
As previously stated, the synchronous rises in Ca2+ leading to
efficient ECC is due, in part, to the tight opposition of RyRs
and LTCCs in the T-tubules in healthy ventricular myocytes.
There is an abundance of literature describing a loss of T-tubules
during HF (Lyon et al., 2009; Guo et al., 2013; Dries et al.,
2018a), In addition to the loss of the concerted effort for
successful ECC that the loss of T-tubules will bring, deleterious
Ca2+ handling leading to arrhythmia may also result. A recent
study investigated the potential mechanisms behind T-tubule
disruption in post-infarction failing rat hearts. In that study,
they showed that elevated wall stress was associated with
disruption of the T-tubular structure and this was associated
with decreased levels of junctophilin 2, which is a critical dyadic
anchor. Furthermore, they carried out studies on loaded papillary
muscles, which confirmed a direct role of wall stress on regulation
of T-tubule organization (Frisk et al., 2016). Taken together these
data indicate the importance that stretch has in developing the
HF phenotype when it comes to subcellular structure of the
myocyte. Alterations in location of relevant signaling pathways
that may also be induced by this loss of cellular architecture
will be discussed later (see the Section “Local (Microdomain)
Remodeling”).
As the current generated via the NCX appears to be the
major player responsible for the ITI that initiates DADs, and
perhaps EADs, one also needs to consider how the function
of this exchanger is altered in HF. Interestingly, a number of
in vitro studies have suggested that stretch of adult myocytes
increases NCX expression (Sipido et al., 2002). These data may
lead us to believe that the increase stretch ‘felt’ by the in situ
myocyte may also lead to an increase in NCX in HF. Indeed,
the majority of studies have shown that NCX is increased
in HF (Sipido et al., 2002; Schillinger et al., 2003), although
we should approach these data with caution due to the fact
that expression levels do not necessarily give an indication of
activity, especially when considering an exchanger where ion
concentrations, phosphorylation state [of partner proteins (e.g.,
phospholemman) as well as NCX itself] in addition to other
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factors will ultimately influence the current generated by the
exchanger.
One of the major influences on NCX activity is the
intracellular Ca2+ concentration. It is well known that
cardiomyocytes isolated from failing hearts (with reduced
ejection fraction) show altered Na+ and Ca2+ haemostasis.
The modified Ca2+ handling is characterized by decreased
Ca2+ transients, enhanced diastolic SR Ca2+ release and
diminished SR Ca2+ reuptake, which all contribute to altered
Ca2+ concentrations ‘seen’ by the NCX (Hasenfuss and Pieske,
2002; Kho et al., 2012; Luo and Anderson, 2013) . Additionally,
modeling studies have shown that that both dyadic and SR Ca2+
influence the appearance of DADs in addition to alterations in
Ca2+ diffusion across the cell and Ca2+ uptake into the SR (Fink
et al., 2011).
One of the first papers investigating Ca2+ sparks in myocytes
from patients with HF indicated that alterations in the Ca2+
release mechanisms must be one of the mechanisms underlying
EC coupling, in addition to alterations in SR Ca2+ load (Lindner
et al., 2002). One of the driving forces behind this is the
altered open probability of RyRs, which is governed by multiple
factors, and has not been without controversy over the years
(Dobrev and Wehrens, 2014). Interestingly, recent work has
shown that stabilizing the RyR, using dantrolene, is able to
prevent DADs in myocytes isolated from HF patients (Hartmann
et al., 2017). Over the next few paragraphs, we will discuss how
the major controllers of RyR stability, that also govern stretch
and/or β-adrenergic signaling (namely CaMKII and ROS), can
be affected in HF.
CaMKII phosphorylation of RyR appears to play an important
role in arrhythmogenesis and sudden cardiac death in mice with
HF (van Oort et al., 2010). Analysis from ventricular tissue from
patients with either dilated or ischemic cardiomyopathy have
shown that there is an increase in the levels of CaMKIIδ, the
major isoform of CaMKII in the heart (Sossalla et al., 2010).
Interestingly, single myocytes isolated from mice overexpressing
CaMKIIδ are more liable to show DADs and spontaneous
APs under β-adrenergic stimulation when compared to wild
type mice (Sag et al., 2009). This increase in CaMKII seen in
HF could directly promote arrhythmia formation by not only
increasing diastolic Ca2+ leak via RyR phosphorylation, but also
by promoting increases in the late Na+ current (Wagner et al.,
2006), a current that has already been shown to be increased
in HF, and incriminated in increased BVR and arrhythmia
formation under these conditions (Maltsev et al., 2007).
The activity of CaMKII itself is under control of many
different regulators, including ROS (as stated above and shown
in Figure 2), which is detrimentally altered in HF. ROS also
as having their own independent effects on RyR and other
components of the Ca2+ handling machinery (dependent on the
source of the ROS). In HF, just as in normal physiology, ROS has a
number of different sources including NOX2, mitochondria and
uncoupled NOS (Sag et al., 2013).
Interestingly, NOX2 expression and/or activity has also
been shown to be increased in end-stage human HF in a
number of studies, supporting the potential involvement of this
pathway in the formation of ROS that may interfere with Ca2+
handling and lead to subsequent arrhythmias (Zhang M. et al.,
2013). Furthermore, the elevated intracellular Na+ concentration
seen in HF promotes the production of mitochondrial ROS
(Kohlhaas et al., 2010; Viatchenko-Karpinski et al., 2014), which
could ultimately lead to the potential for a vicious circle of
proarrhythmic signaling via CaMKII.
Diseased hearts have been shown to have a significant increase
in nNOS mRNA and protein expression (Damy et al., 2004).
While on the other hand, several studies have provided evidence
that NO production by eNOS is markedly diminished in HF,
and an overexpression of eNOS has been shown to relieve
cardiac dysfunction in a mouse model of HF (Katz et al.,
1999; Jones et al., 2003; Damy et al., 2004). Under normal
physiological conditions eNOS appears to decrease β-adrenergic
responsiveness via inhibition of LTCC (Wang et al., 2008),
therefore a reduction in this mechanism may be an additional
driving force for β-adrenergic driven arrhythmias under these
conditions. The overall increase in nNOS activity in HF, and
the potentially altered signaling activity and targets (for example
caveolae-associated molecules versus the RyR) resulting from
the translocation of this molecule to the sarcolemma, may
be important for deleterious Ca2+ handling and arrhythmia
formation (Damy et al., 2004). Additionally, in HF it appears
that NO production inducible NOS (iNOS) becomes of increased
importance, although the role of this is currently less defined
(Massion et al., 2003; Carnicer et al., 2013).
The activity of cAMP/PKA is tightly regulation by the activity
of specific phosphodiesterases (PDEs) and protein phosphatases,
however, the distribution of these is out of the scope of the present
manuscript (see Guellich et al., 2014 for a review on this matter).
Finally, it is important to consider that the relative
contribution of the different subtypes of β-ARs may also
contribute to the increased arrhythmogenic phenotype observed
in HF. As noted previously distinct pathways are associated
with the different subtypes. Previous work has shown that the
β1 subtype of adrenoreceptors are especially downregulated in
HF, while the coupling of the receptors to Gs, presumably via
increased activity of the receptor kinases GRK2 and/or GRK5, is
altered (Lohse et al., 2003). Interestingly, β2-stimulation appears
to be more arrhythmogenic in the failing heart when compared
to the non-failing. Arrhythmogenesis appears to be driven by
enhanced spontaneous SR Ca2+ release and aftercontractions,
and is likely attributable, at least in part, to enhanced SR Ca2+
load secondary to PLB phosphorylation (DeSantiago et al., 2008).
Away from the single cardiac myocyte, the requirement for
β-Adrenergic stimulation to induce ectopic activity has also been
shown in a human wedge preparation. Hearts from patients
experiencing HF, exhibited ectopic beats and triggered activity in
response to β2-stimulation. The authors of this study ascribe the
increase in arrhythmogenic activity due to the enhancement of
transmural differences between Ca2+ and APD, facilitating the
formation of DADs (Lang et al., 2015).
All of the data that has been discussed up till now has not
considered the potential for regional differences in remodeling,
which may be triggered by various stimuli, stresses and strains
sensed at different anatomical locations. Taking this into account,
a recent paper interestingly showed that in a porcine model
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of myocardial infarction and HF, regional heterogeneities in
arrhythmogenic remodeling do indeed exist. In this study, it was
shown that changes in multiple currents lead to a shortening
of AP at the border zone of the infarct, while APs recorded
from the remote zone were prolonged. This will lead to a greater
dispersion of repolarization across the ventricle, which could
ultimately increase the arrhythmogenic substrate. Furthermore,
these authors showed that cells isolated from the remote region
showed DADs with a much higher frequency than in control,
and amongst those cells, nearly half also showed triggered APs.
Interestingly all HF-border cells showed DADs with over half
showing triggered activity often with a superimposed EAD. In
addition, inhibition of CaMKII decreased the occurrence of these
DADs back to control levels, further indicating the importance
of this multimodal signaling molecule in arrhythmia generation
in this setting (Hegyi et al., 2018b). Although in this study these
DADs were not induced by β-Adrenergic stimulation, but by
burst pacing, one could also postulate that regional differences
will also exist in terms of β-Adrenergic responsiveness in HF. In
fact, a recent abstract from the Sipido group showed that in a
pig model of MI, myocytes isolated from the peri-infarct region
had a higher occurrence of isoproterenol induced DADs when
compared to myocytes isolated from the region remote from the
infarct (Dries et al., 2018b). These data pave the way for further
research in this area.
Local (Microdomain) Remodeling
So far, we have only focussed on global remodeling, however, in
addition to heterogeneity seen across the ventricular wall as just
described, the myocyte in itself is not homogeneous, especially
when the micro-architecture of the myocyte is altered as is seen
in HF. For these reasons, we must also consider local subcellular
alterations. Given the improvements in imaging techniques,
and experimental advances over recent years we have gained
greater insights into how alterations in these ‘microdomains’
may influence arrhythmogenic outcomes in HF. Over the next
paragraphs, we will discuss a number of studies that have been
carried out in an attempt to elucidate how these microdomains
may influence stretch- or β-adrenergic-induced arrhythmia in
HF, with a view on targeted therapeutics (see the Section
“Therapeutic Interventions”).
As noted previously, Ca2+ entry via the LTCC is the initial
trigger for Ca2+ release from the SR, therefore it is important
to discuss potential changes in this current in HF. At a global
level, the majority of studies have shown that there is no alteration
in whole cell Ca2+ current recorded from myocytes from HF
patients or in animal models, although single channel studies
have shown that the availability and open probability of the
LTCC is increased in human HF myocytes (Beuckelmann and
Erdmann, 1992; Mukherjee and Spinale, 1998; Schröder et al.,
1998). However, over recent years a number of interesting
observations have come to light indicating the location of LTCCs
are different in HF myocytes. Alteration in the location of
the LTCC will also have detrimental effects on the levels of
Ca2+ the individual channels are exposed to. Therefore, Ca2+-
dependent inactivation of the current as well as the dynamic
modulation of the window current are likely to be altered in
HF. Both of these changes will contribute to the formation
of afterdepolarizations and can be influenced by β-adrenergic
stimulation.
Using a rat model, combined with osmotic detubulation,
Bryant et al. (2015) showed that although no differences in total
ICaL density was seen between ventricular myocytes isolated from
animals that had undergone a coronary artery ligation, this lack
of change resulted from differential effects at the cell surface
and the T-tubules. ICaL current density was decreased at the
T-tubules while it was increased at the cell surface (Bryant et al.,
2015).
An additional study from the group of Gorelik, using
the super-resolution scanning patch-clamp technique showed
similar findings. They elegantly showed that in both human
and rat HF there was a redistribution of functional LTCCs
from their physiological T-tubular location to the non-native
crest of the sarcolemma. They went on to show that the open
probability of these redistributed channels was dramatically
increased, and the high open probability was linked to
enhanced CaMKII modulation in the ‘new’ location. The
current at these non-native channels resulted in an elevated
ICaL window current, which contributed to the development
of EADs. This remained true when these data were fed-
into a 3-dimensional left ventricle model illustrating that the
phenomenon occurring at the single cell level has far reaching
arrhythmogenic implications (Sanchez-Alonso et al., 2016).
Interestingly, work carried out over 20 years ago indicated
that there was a frequency dependent decrease in ICaL in
human dilated cardiomyopathy (Sipido et al., 1998). If this is
to do with the altered LTCC microdomains, potentially due to
CaMKII, remains to be seen, but should be the subject of future
studies.
Localization of the LTCC to the T-tubules has previously
been shown to be under control of the membrane scaffolding
protein BIN1, with the knockdown of this protein leading to
a reduction in surface LTCC and alterations in Ca2+ handling
within the myocyte (Hong et al., 2010). Interestingly, BIN1
has been shown to be decreased in human HF as well as
in a number of animal models, which may contribute to the
alterations in patterns seen in LTCC localization (Hong et al.,
2012; Caldwell et al., 2014). A more recent study has implicated
that the β-adrenergic stimulation of BIN1 leads to reorganization
of LTCC/RyR microdomains by also recruiting phosphorylated
RyRs into the dyads. When BIN1 is downregulated, therefore,
these phosphorylated RyRs may not be recruited in the dyad
and arrhythmias may be promoted due to the defective Ca2+
handling (Fu et al., 2016).
Over 10 years ago, it was shown that in the failing heart
there are a number of RyRs that become ‘orphaned’ from
their LTCC counterpart in the T-tubule in spontaneously
hypertensive rats (Song L.S. et al., 2006). These investigators
used this model to show that this loss of coupling between
the LTCC and RyR led to Ca2+ instability in the heart.
More recently, Dries et al. (2018a) showed that in human
myocytes isolated from HF patients, there were more non-
coupled (to LTCC) RyRs which had more spontaneous activity
than in non-HF. Hyperactivity of these non-coupled RyRs
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was reduced by CaMKII inhibition (Dries et al., 2018a).
Previous work from the same group had illustrated that under
healthy conditions, coupled (to LTCC) RyRs are distinctly
modulated by CaMKII and ROS, while CaMKII and NOS1-
dependent modulation of RyRs during β-adrenergic stimulation
was also restricted to the dyadic cleft (Dries et al., 2013,
2016). The authors went on to use a pig model to further
investigate alterations in coupled and non-coupled RyRs and
their regulation in normal and pathophysiological conditions.
However, after an MI, it was shown that under adrenergic
stimulation using isoproterenol, Ca2+ waves were frequent
and originated at non-coupled sites, generating larger NCX
currents than in sham operated animals. Inhibition of CaMKII
or mitochondrial-ROS scavenging reduced spontaneous Ca2+
waves, and improved excitation–contraction coupling, indicating
that these could be interesting therapeutic targets (Dries et al.,
2018a). A very recent paper corroborated the arrhythmogenic
role of mitochondrial ROS in the formation of arrhythmias
in a guinea pig model of non-ischemic HF (Dey et al.,
2018). In this model, continuous telemetry recordings indicated
a high frequency of premature ventricular complexes and
spontaneous ventricular tachycardia/ventricular fibrillation in
animals after aortic constriction and isoproterenol stimulation.
Scavenging mitochondrial ROS using MitoTEMPO markedly
suppressed arrhythmias as well as blunting QT prolongation and
reducing QT variability. Taken all together these data indicate
specific targeting of one source of ROS is adequate to reduce
proarrhythmic outcomes.
In addition to alterations seen in the LTCC/RyR microdomain,
and the control thereof, that may influence arrhythmogenesis
we also need to consider alterations in the distribution of the
different β-ARs themselves. One of the first reports investigating
potential alterations was by Nikolaev et al. (2010). In that seminal
study it was shown that, as opposed to the situation in healthy
myocytes where β1-adrenergic receptors are widely distributed
at the cell crest and β2-receptors (and their associated signaling
pathways) are localized to the T-tubules, in HF β2-receptors
were redistributed from the transverse tubules to the cell crest,
leading to a change in β2-receptors associated compartmentation
of cAMP (Nikolaev et al., 2010). These alterations lead to the
β2-receptors acting more like β1-receptors and have detrimental
effects on the cross-talk of adrenergic signaling and Ca2+
handling within the failing cell. Follow up studies have shown
that the compartmentalization of the cAMP signaling from β2-
receptors is governed by caveolin 3, a protein that regulates the
number of caveolae in the myocyte. Alteration in the T-tubule
structure, levels of caveolin 3 and junctophilin 2 appear to be
time-dependent, and gradually alter the β2-signaling pathways.
Furthermore, caveolin 3 overexpression in failing cells was able to
restore, at least in part, the T-tubular location of the β2-receptors
(Wright et al., 2014; Schobesberger et al., 2017).
Interestingly, an additional study utilizing a rabbit model,
also showed that reintroduction of caveolin-3 was able to
normalizes β-adrenergic-induced contractile responses in HF
myocytes, while also showing that in HF β2-induced signaling
gains access to myofilament which may contribute to abnormal
PKA phosphorylation of troponin I and contractile dysfunction
(Barbagallo et al., 2016). In addition, work from the Sacconi
group has shown that while cells from HF myocytes respond to
β-adrenergic stimulation, this is not the case at the T-tubules that
do not conduct APs, where the alterations seen in response may
be caused by a lack of electrical activity. These data provide an
alternative, or an additional, mechanism for the alterations seen
in HF (Crocini et al., 2016).
THERAPEUTIC INTERVENTIONS
Despite advances in our knowledge of the pathophysiology
underlying HF over the last 10 years, as outlined above,
only a limited number of compounds have become available
for the treatment of this debilitating disease (Gordin and
Fonarow, 2016). Given the information in previous sections,
we could consider targeting primary stressors (i.e., β-adrenergic
stimulation or mechanical load) or downstream pathways.
In Figure 3, we have summarized the most important
mechanisms of afterdepolarizations, highlighting relationships
between stimuli, key signaling molecules and targeted Ca2+
handling proteins and ion currents. Based on this scheme, we will
discuss a number of (potential) interventions over the next few
paragraphs that could be utilized to reduce the arrhythmogenic
burden in HF patients.
Targeting Mechanical Load and
Structural Remodeling
β-Blockers have been a mainstay of pharmacological treatment
for HF for a number of years and are included in guidelines for
treatment of HF, in part due to their antiarrhythmic properties
(Funck-Brentano, 2006; Ponikowski et al., 2016). In addition to
a reduction in β-adrenergic signaling that will be directly caused
by β-blockers, they will also lead to a reduction of mechanical
stressors that may also be responsible for the efficacy of β-blockers
in preventing sudden cardiac death.
Not all β-blockers are equal, however, with some being
selective at adrenoreceptor subtypes while others have additional
actions at other ion channels. For instance, the antiarrhythmic
effects of propranolol have also been ascribed to the potential
of this compound to block Na+ channels (Fabritz et al., 2014).
In long QT syndrome, for instance, it has been shown that
propranolol has a significantly better QTc shortening effect
compared to metoprolol and nadolol, and this led to a higher risk
of cardiac events in symptomatic patients receiving metoprolol
(Chockalingam et al., 2012). Therefore, given the information
we currently have regarding the alteration in the number and
location of subtypes of the β- receptors in HF, specific targeting
of β-ARs, perhaps differing over the course of HF progression,
may offer an interesting solution.
An additional way that mechanical load can be reduced is
by the used of LVADs. Previous work has shown that the use
of a LVADs together with the use of a specific pharmacological
regimen, including the use of β-blockers, can lead to the
sustained reversal of severe HF secondary to non-ischemic
cardiomyopathy, even when the LVAD is explanted (Birks et al.,
2006). Interestingly, it appeared that the alterations seen in the
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FIGURE 3 | Scheme of key events in β-adrenergic and stretch signaling for the induction of afterdepolarizations as potential targets for anti-arrhythmic therapy. The
central event in the generation of afterdepolarizations is a Ca2+ wave that can produce DAD or EAD depending on the timing of NCX activation during the cardiac
cycle (diastole or systole). Mechanical stretch and β-adrenergic agonists activate protein kinases (PKA, CaMKII) and free radicals (ROS, NO) that increase RyR
activity and/or SR Ca2+ load to produce Ca2+ sparks and waves. Likewise, they increase the activity of late Na+ and Ca2+ currents promoting EADs, directly via
phosphorylation and redox modification, or indirectly via modulation by increased SR Ca2+ release secondary to enhanced SR Ca2+ load. Stretch-activated ion
channels further destabilize membrane potential during stretch. Anti-arrhythmic strategies include targeting of upstream stressors, downstream signaling
components, and Ca handling proteins or currents. Specific examples under current investigation are indicated and further discussed in the text. DAD, delayed
afterdepolarizations; EAD, early afterdepolarizations; LVAD, left ventricular assistant device; NCX, Na+/Ca2+ exchanger; NO, nitric oxide; NOX, NADPH oxidase type;
nNOS, neuronal nitric oxide synthase; PKA, protein kinase A; ROS, reactive oxygen species; RyR, ryanodine receptor; SACNS, stretch-activated non-selective
cation currents; SR, sarcoplasmic reticulum; SERCA, SR Ca2+-ATPase.
clinical phenotype in such patients was driven by modifications
in ECC, and SR Ca2+ homeostasis in particular (Terracciano
et al., 2004). More recent work has shown that mechanical
unloading in a rat model (via heterotopic abdominal heart
transplantation) reverses T-tubule remodeling, and normalizes
local Ca2+ handling (Ibrahim et al., 2012).
Cardiac resynchronization therapy (CRT) is an alternative
approach to alter mechanical loading and stretch and will assist
to resynchronize ventricular wall motion. A recent meta-analysis
indicated that this intervention may significantly reduce the
risk of ventricular arrhythmias when compared with patients
receiving ICDs. Interestingly the same study also showed that
patients who were not-responsive to CRT may have had a
significantly higher risk of ventricular arrhythmias (Saini et al.,
2016). Furthermore, it was also shown that CRT was able
to efficiently reduce subcellular heterogeneity of structure and
function of RyRs and T-tubules in a canine model of HF,
potentially due to the restoration of ventricular synchrony (Li
et al., 2015).
Taking all of these data together it appears that alterations in
mechanical load should be considered as a potential therapeutic
strategy.
Another therapeutic strategy would be to potentially restrict
remodeling in the first place. As previously mentioned, it
appears there are a number of scaffolding proteins that are
involved in the structural (and functional) remodeling of
the Ca2+ microdomains in HF which could be the target
for pharmaceutical intervention. For example, specific cardiac
targeting of BIN1 could be an attractive option, although there
are only limited data currently available and small molecules
altering the activity of this protein are currently lacking. The
potential for altering the T-tubule structure as a therapeutic
intervention has recently been reviewed by Manfra et al.
(2017).
Direct Targeting
It could also be possible to directly target proteins involved in
arrhythmia formation under conditions of enhanced stretch or
intense ß-adrenergic stimulation. For example, the potential to
target stretch activated channels was recently reviewed by White
(2006), however, it is perhaps of note to mention GsMTx-4, which
is a peptide isolated from tarantula venom. Mixed results have
been obtained with GsMTx-4 to date, with one study showing the
potential for reducing the number of premature ventricular beats
in an ischemia/reperfusion mouse model, while an additional
study indicated no benefit in a swine model (Barrabés et al.,
2015; Wang et al., 2016). Further studies are required using this
compound, and derivatives of it, to truly delineate the utility of
inhibition of these channels in prevention of arrhythmogenesis
in HF.
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Furthermore, the blockade of the components of ITI
which actually contributes to afterdepolarization could also
be an interesting target. Inhibition of NCX as a target has
been discussed previously (Antoons et al., 2012), however,
progress in this area has been hampered the lack by selective,
and/or mode selective inhibitors. More recently a number of
more selective agents have been developed, including ORM-
10103 which have shown their utility in preventing Ca2+
overload induced arrhythmias (Nagy et al., 2014). However,
in a rabbit HF model NCX inhibition with ORM-10103
reduced premature ventricular beats but was unable to suppress
secondary Ca2+ rise or the occurrence of EADs (Chang et al.,
2018).
Direct inhibition of ‘leaky’ RyRs could also be an interesting
target to diminish proarrhythmic Ca2+ leak. A recent paper
showed the utility of a tetracaine-derived compound, EL20,
which was able to limit arrhythmogenic Ca2+ waves in
a CPVT model by only limiting Ca2+ release from RyRs
associated with calmodulin (Klipp et al., 2018). Should
this have utility in HF should be the subject of further
investigation.
An alternative approach would be to alter the activity of
SERCA in HF. A number of pre-clinical studies showed that
there was anti-arrhythmic potential for increasing SERCA
activity in HF using adeno-associated virus technology
(Kawase et al., 2008; Lyon et al., 2011). Despite initial
positive outcomes in small trials (Jessup et al., 2011), larger
clinical trials have been unable to show the benefit of this
approach (Greenberg et al., 2016; Hulot et al., 2017). Despite
these disappointing results, further studies are still required
to investigate the true utility of this approach. Activation
of SERCA using small molecules may also be potentially
interesting approach, and recently istaroxime has become a
compound of interest (Ferrandi et al., 2013). A clinical trial
using this compound is currently ongoing (ClinicalTrials.gov
Identifier: NCT02617446) with the results being highly
anticipated.
Targeting Downstream Modulation
An alternative avenue would be to target downstream signaling
pathways that are involved. Perhaps one of the most investigated
of these is the CaMKII pathway, perhaps due to the multimodal
action of this kinase, and the fact that targeting this molecule
may lead to selective modulation of proarrhythmic RyRs (Dries
et al., 2018a). Interestingly it was recently shown that CaMKII
activity persists even during chronic β-adrenergic blockade
in HF, indicating that these two pathways could be targeted
independently (Dewenter et al., 2017). To date, however, there
are no clinically available CaMKII inhibitors, likely due to the
lack of selective, bioavailable compounds. There are numerous
reviews dealing with the potential of CaMKII inhibition as a
potential treatment for HF, and for those reasons we will only
discuss a couple of newer studies that have added fuel to the
fire regarding the use of CaMKII inhibitors as antiarrhythmics
(Swaminathan et al., 2012; Fischer et al., 2013; Westenbrink et al.,
2013).
A recent study utilized the novel agent, GS-680, which
is an ATP-dependent small molecule inhibitor of CaMKII,
which appears to have good selectivity for CaMKII. In this
study, this compound did not impair contractile function in
failing human ventricular trabeculae and blunted the negative
force-frequency relationship. Meanwhile, it increased the Ca2+
transient amplitude in isolated failing ventricular myocytes and
reduced premature atrial contractions and afterdepolarizations
in atrial cardiomyocytes (Lebek et al., 2018). Additionally, Dries
et al. (2018a) recently showed that the specific CaMKII peptide
inhibitor (AIP) significantly reduced the hyperactivity of RyRs
in non-coupled regions without affecting spark frequency at
coupled sites (Dries et al., 2018a). Finally, it has also been shown
that inhibition of CaMKII is able to reduce the proarrhythmic
effects of PDE-inhibitors, which act by increasing pools of cAMP
(Bobin et al., 2016). If this is also true in HF should be the subject
of future studies. If CaMKII inhibition will eventually function as
an effective antiarrhythmic in HF still remains to be seen. While
discussing CaMKII, it is also important to discuss the late Na+
current. Recent work has shown that inhibition of this current is
able to suppress Ca2+ related arrhythmias by reducing CaMKII
phosphorylation (Wei et al., 2017). Furthermore, ranolazine, an
agent that inhibits both late Na+ and K+ channels has been
shown to have antiarrhythmic effects in the intact heart in
CHF and, interestingly, was not associated with drug-induced
proarrhythmia (Frommeyer et al., 2012). Once again, further
work is required to determine the true utility of late Na+ current
inhibition under these circumstances.
Reactive oxygen species is one of the determinants of CaMKII
activity, as well as having direct effects on Ca2+ handling proteins
directly, so perhaps it is also possible to target ROS sources as
an antiarrhythmic intervention. Interestingly the positive effect
of the antioxidant vitamin C on the β-adrenergic response to
dobutamine was blunted in HF patients, perhaps due to the
global antioxidant properties of this agent (Mak and Newton,
2004), leading us to believe that a targeted approach may be
required. The inhibition of NOX2 may be a promising approach
although it may be necessary to avoid concurrent inhibition
of other NADPHs which are required in other organ systems
(Sag et al., 2014). Furthermore, supplementing with BH4, to ‘re-
couple’ uncoupled NOS has been proposed (Moens et al., 2008),
however, there have been issues with the bio-availability of this
compound (see Bendall et al., 2014). The final source of ROS
that could be an interesting target in mitochondrial ROS, and
as noted earlier a number of studies have shown the utility of
mitoTEMPO in reducing arrhythmia in HF (Dey et al., 2018;
Dries et al., 2018a). The development of bioavailable safe tools to
directly alter mitochondrial ROS production is still in its infancy
and efforts should be concentrated to develop these.
Finally, targeting Epac has also been proposed as a potential
target for arrhythmias driven by β-adrenergic stimulation,
although there is discussion about its role. A recent study
showed that treatment with an Epac activator, 8-CPT, enhanced
the late Na+ current while inhibition of PKA (via PKI) did
not affect the catecholamine induced increases in late Na+
current, indicating that Epac alone plays a crucial role in
these arrhythmias (Dybkova et al., 2014; Fujita et al., 2017).
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CONCLUDING REMARKS
We still have a long way to go in treating ventricular arrhythmias
that occur as a result of HF, however, concentrating on various
microdomains within the cardiac myocytes that are under control
of multiple pathways could be of great interest. Furthermore,
linking the potential electro-mechanical and mechano-electro
feedback loops could aid us in treating arrhythmias that occur
as a result of this debilitating disease.
Is stretch sympathetic to HF? Only time and research will fully
answer this question, but in the mean time we will have to be.
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